Cycling to protect the ankle joint in gout
Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism clinical trials.
This trial tests whether regular cycling can help protect your ankle joint if you have gout. You'll be asked to cycle as part of the study, and the goal is to see if it reduces the risk of future attacks and joint damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a formal gout diagnosis from a doctor.
- You must have had two gout flare-ups in your ankle in the past six months.
- An ankle ultrasound in the last six months must show gout-related signs like crystals or joint damage.
- Your last gout attack must have been at least four weeks ago.
- If you take uric acid-lowering medication, the dose must have been stable for at least four weeks.
- If you could become pregnant, you must have a negative pregnancy test and agree to use birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medicine called SSGJ-613 to see if it can reduce gout flares when people start treatment to lower uric acid. It may help people who have frequent gout attacks.
This trial tests whether nurse-led telehealth visits can help people with gout maintain healthy urate levels. If you have gout and are already on medication like allopurinol, this study may offer a convenient way to manage your condition from home.
This study compares two different treatment goals for a blood level called urate in people with gout. The goal is to see which approach lowers gout flares better while helping people feel better.
This study looks at whether people with gout whose uric acid is well controlled and whose joints are clear on ultrasound can safely stop their daily uric acid-lowering medication. Participants are randomly assigned to either continue their current medication or stop it, and their health is monitored to see if stopping leads to gout flares or joint damage.
This trial tests a new medication, ABP-745, for people having an acute gout flare. It aims to see if the drug is safe and helps reduce pain and inflammation.
This trial tests whether extra diet advice helps people with gout who are already taking urate-lowering medicine. It might help them manage their condition better.
Hear when a new Gout Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.